HLA-C and lung carcinoma: Another report suggested that because LKB1-deficient lung cancer exhibiting high autophagy activity tends to decrease MHC presentation through autophagic degradation, autophagy inhibition enables the recovery of MHC class antigen presentation and further enhances the therapeutic effect of immune checkpoint inhibitors (ICIs) in lung cancer models [162].